Drug details
Peg-Intron (peginterferon alfa-2b)
type of Hepatitis B Hepatitis C Agents
PegIntron (peginterferon alfa-2b) is an interferon used to treat chronic hepatitis C in patients with compensated liver disease.
The drug is often used to treat Hepatitis C , Liver disease .
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- rash that spreads and causes blistering and peeling,
- nausea,
- loss of appetite,
- vomiting,
- diarrhea,
- fever,
- easy bruising,
- unusual bleeding,
- pale skin,
- lightheadedness,
- shortness of breath,
- cold hands and feet,
- confusion,
- chills,
- tiredness,
- chest pain,
- dry mouth,
- increased thirst,
- increased urination,
- fruity breath odor,
- mouth sores,
- sudden numbness or weakness,
- loss of consciousness
- drowsiness,
- yellowing of the skin or eyes (jaundice), and
- anxiety,
- aggression,
- thoughts of self-harm,
- slurred speech,
- depression,
- irritability,
- hallucinations,
- vision changes,
- new or worsening cough,
- skin sores,
- cough with mucus,
- severe pain in your upper stomach spreading to your back,
- thinking problems,
- weight changes,
- swelling around your midsection,
- skin changes,
- falling back into a previous pattern of drug addiction,
- severe stomach pain with bloody diarrhea,
- problems with balance,
- feeling hostility,
- numbness, tingling, or burning in your arms or legs,
- feeling hot or cold all the time,
The following drugs are related to Peg-Intron, either as a replacement or used together:
- Cabometyx (cabozantinib tablets)
- Imlygic (talimogene laherparepvec suspension for intralesional injection)
- Technivie (ombitasvir, paritaprevir and ritonavir tablets)
- Viekira Pak (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets)
- Pegasys (peginterferon alfa-2a)
- Plegridy (peginterferon beta-1a injection for subcutaneous use)